November 14, 2024 - 05:39

When faced with the need for new bedside care tools, health care systems often grapple with a critical decision: should they build a custom solution or purchase an established product? Each option comes with its own set of advantages and challenges, making it essential to evaluate the specific needs of the organization.
Building a custom solution allows for tailored features and functionalities that align perfectly with the unique requirements of the healthcare setting. This approach can foster innovation and provide a competitive edge. However, it also demands significant investment in time, resources, and expertise. Developing in-house solutions can lead to longer implementation times and may require ongoing maintenance and support.
On the other hand, purchasing a proven product offers immediate access to a tested solution that other hospitals have successfully implemented. This route can save time and reduce the risks associated with product development. Established products often come with vendor support and updates, ensuring that the technology remains current. However, these solutions may not fully meet the specific needs of every organization, leading to potential compromises in functionality.
Ultimately, the decision to build or buy should consider factors such as budget, timeline, and the complexity of the desired solution. A thorough assessment of both options will help ensure that the chosen path best addresses the immediate and long-term needs of the healthcare system.
July 22, 2026 - 02:43
FPT Partners with Nuummite and e-CENS to Explore Strategic Technology Collaboration Across the Middle East and AfricaHANOI, Vietnam, July 22, 2026 -- Global technology firm FPT has signed a Strategic Cooperation Agreement with Nuummite, a digital transformation and intelligent automation company based in the...
July 21, 2026 - 21:44
How technology and acquisition reform are propelling Navy submarine productionThe U.S. Navy is turning to a mix of modern technology and streamlined purchasing rules to speed up the construction of its submarine fleet, a move aimed at closing a long-standing gap between...
July 21, 2026 - 04:33
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping TechnologySAN DIEGO, July 20, 2026 -- TriLink BioTechnologies, a Maravai LifeSciences company and a global supplier of life science reagents and services, has secured a new patent in China. The patent,...
July 20, 2026 - 02:29
'Going blue': Israel invests in marine-related renewable energies with Innovation Authority fundThe Israeli government has announced a new investment initiative aimed at advancing renewable energy technologies tied to the sea. Dubbed `Going Blue,` the program will channel a total of NIS 6...